Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

Share this content:

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

Sponsor and Collaborators     
University of Pittsburgh
National Institutes of Health (NIH)

Contact    
Jodi K. Maranchie, MD     
412-605-3019     
maranchiejk@upmc.edu

Kimberly Jones, RN BSN     
412-623-2764     

Investigator
Jodi K. Maranchie, MD     
University of Pittsburgh

ClinicalTrials.gov Identifier
NCT01144169

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs